Status:

COMPLETED

Clip Marker Placement in Primary Lesions of Breast Cancer Patients Receiving Neoadjuvant Therapy

Lead Sponsor:

Kliniken Essen-Mitte

Conditions:

Primary Breast Cancer

Eligibility:

FEMALE

18+ years

Brief Summary

Neoadjuvant systemic therapy (NST) is increasingly recommended for patients with early breast cancer, and the rate of patients with pathological complete remission (pCR) is increasing due to the use o...

Detailed Description

Breast cancer patients whose carcinomas have an aggressive tumor biology which implies the need for chemotherapy are increasingly being treated with NST. As a standard procedure, clip placement of the...

Eligibility Criteria

Inclusion

  • female patient aged ≥ 18 years
  • written informed consent
  • patient's consent to NST
  • suspicious unilateral or bilateral intramammary foci that can be safely identified by ultrasound
  • no evidence of distant metastasis (complete staging does not have to be present at inclusion)
  • indication for breast conserving therapy
  • no prior clip placement in the confirmed intramammary carcinoma
  • patient is able to undergo NST treatment (even if the indication based on tumor biology is not yet available)
  • high compliance and high number of planned relevant surgical interventions in participating study center
  • patient can understand the scope of this prospective registry study

Exclusion

  • allergy to titanium and/or nickel
  • pregnancy
  • ipsilateral relapse (when NST: no exclusion criterion)
  • prior extensive breast surgery (starting from quadrant resection)
  • inflammatory breast cancer
  • extramammary breast cancer
  • multicentric or multifocal breast cancer
  • patient is not operable
  • patient is already undergoing adjuvant/neoadjuvant therapy
  • inability to understand the purpose of the clinical trial or to comply with study procedures

Key Trial Info

Start Date :

May 14 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 30 2023

Estimated Enrollment :

339 Patients enrolled

Trial Details

Trial ID

NCT04468113

Start Date

May 14 2020

End Date

July 30 2023

Last Update

November 24 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Interdisciplinary Breast Unit, Kliniken Essen-Mitte

Essen, Germany, 45136